GGrantIndex
← Leaderboards

Sridhar Mani

University Of Washington

$6,137,733
Attributed
$9,801,973
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,801,973 · 5

By mechanism

R01$9,790,223 · 4
R13$11,750 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Complex

Research focus

ComplexPregnane X ReceptorReceptorCellsNuclear ReceptorsToxic EffectIntestinesMicrobialStructureLeadPharmaceutical PreparationsTissuesAgonistBaseLigandsPhenotypeReceptor ActivationMediatingAcuteMetabolismLifeLaboratoriesPlayAntineoplastic Agents

Grant awards (30)

Developmental flame retardant exposure, gut microbiome, and obesity$523,875
R01 · FY2025 · ES
Developmental flame retardant exposure, gut microbiome, and obesity$1
R01 · FY2025 · ES
Developmental flame retardant exposure, gut microbiome, and obesity$679,987
R01 · FY2024 · ES
Developmental PBDE exposure, gut microbiome, and diabetes$596,584
R01 · FY2023 · ES
Developmental PBDE exposure, gut microbiome, and diabetes$606,172
R01 · FY2022 · ES
Microbial Metabolite Mimics, PXR and Colitis-Induced Colorectal Cancer$374,573
R01 · FY2022 · CA · contact PI
Developmental PBDE exposure, gut microbiome, and diabetes$616,474
R01 · FY2021 · ES
Microbial Metabolite Mimics, PXR and Colitis-Induced Colorectal Cancer$371,820
R01 · FY2021 · CA · contact PI
Developmental PBDE exposure, gut microbiome, and diabetes$626,238
R01 · FY2020 · ES
Microbial Metabolite Mimics, PXR and Colitis-Induced Colorectal Cancer$502,449
R01 · FY2020 · CA · contact PI
Developmental PBDE exposure, gut microbiome, and diabetes$664,850
R01 · FY2019 · ES
Microbial Metabolite Mimics, PXR and Colitis-Induced Colorectal Cancer$495,752
R01 · FY2019 · CA · contact PI
Microbial Metabolite Mimics, PXR and Colitis-Induced Colorectal Cancer$331,156
R01 · FY2018 · CA · contact PI
Microbial Metabolite Mimics, PXR and Colitis-Induced Colorectal Cancer$218,150
R01 · FY2018 · CA · contact PI
Development of Novel Drugs to Alleviate CPT-11 Toxicity$325,379
R01 · FY2016 · CA · contact PI
Development of Novel Drugs to Alleviate CPT-11 Toxicity$326,465
R01 · FY2015 · CA · contact PI
Development of Novel Drugs to Alleviate CPT-11 Toxicity$1
R01 · FY2015 · CA · contact PI
Development of Novel Drugs to Alleviate CPT-11 Toxicity$317,989
R01 · FY2014 · CA · contact PI
Chemical Modulation of Orphan Nuclear Receptor Function$76,985
R01 · FY2014 · CA · contact PI
Development of Novel Drugs to Alleviate CPT-11 Toxicity$279,335
R01 · FY2013 · CA · contact PI
Chemical Modulation of Orphan Nuclear Receptor Function$251,256
R01 · FY2013 · CA · contact PI
Chemical Modulation of Orphan Nuclear Receptor Function$65,131
R01 · FY2013 · CA · contact PI
Development of Novel Drugs to Alleviate CPT-11 Toxicity$315,319
R01 · FY2012 · CA · contact PI
Chemical Modulation of Orphan Nuclear Receptor Function$267,293
R01 · FY2012 · CA · contact PI
Chemical Modulation of Orphan Nuclear Receptor Function$69,288
R01 · FY2012 · CA · contact PI
Chemical Modulation of Orphan Nuclear Receptor Function$267,293
R01 · FY2011 · CA · contact PI
Chemical Modulation of Orphan Nuclear Receptor Function$69,288
R01 · FY2011 · CA · contact PI
6th International Conference on SBDS$11,750
R13 · FY2011 · DK · contact PI
Chemical Modulation of Orphan Nuclear Receptor Function$275,560
R01 · FY2010 · CA · contact PI
Chemical Modulation of Orphan Nuclear Receptor Function$275,560
R01 · FY2009 · CA · contact PI